Novel variant of CYP2D6*6 is undetected by a commonly used genotyping procedure

Pharmacological Reports

Volumn 63, Issue 5, 2011, Pages 1264-1266

  Rasmussen, Henrik Berg ^a   Werge, Thomas ^a  

^a Mental Health Center Glostrup   (Denmark)

Author keywords

5' exonuclease assay; CYP2D6 genotyping; Novel variant

Indexed keywords

CYTOCHROME P450 2D6; PHOSPHODIESTERASE I; RESTRICTION ENDONUCLEASE;

ALLELE; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ARTICLE; ENZYME ASSAY; GENETIC IDENTIFICATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; NUCLEOTIDE SEQUENCE; RESTRICTION MAPPING;

EID: 83155192317     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/s1734-1140(11)70649-1     Document Type: Article

References (8)

1. Bradford LD: CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics, 2002, 3, 229-243.
2. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Sayers EW: GenBank. Nucleic Acids Res, 2011, D32-37.
3. Daly AK, Leathart JB, London SJ, Idle JR: An inactive cytochrome P450 CYP2D6 allele containing a deletion and a base substitution. Hum Genet, 1995, 95, 337-341.
4. Evert B, Griese EU, Eichelbaum M: Cloning and sequencing of a new non-functional CYP2D6 allele: deletion of T1795 in exon 3 generates a premature stop codon. Pharmacogenetics, 1994, 4, 271-274.
5. Kobylecki CJ, Jakobsen KD, Hansen T, Jakobsen IV, Rasmussen HB, Werge T: CYP2D6 genotype predicts antipsychotic side effects in schizophrenia inpatients: a retrospective matched case-control study. Neuropsychobiology, 2009, 59, 222-226.
6. Marez D, Legrand M, Sabbagh N, Lo Guidice JM, Spire C, Lafitte JJ, Meyer UA, Broly F: Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution. Pharmacogenetics, 1997, 7, 193-202. (Pubitemid 27290633)
7. Oesterheld JR: 2D6. In: Clinical manual of drug interaction principles for medical practice. Eds. Wynn GH, Oesterheld JR, Cozza KL, Armstrong SC, American Psychiatric Publishing, Inc., Washington, DC, 2009, 77-97.
8. Saxena R, Shaw GL, Relling MV, Frame JN, Moir DT, Evans WE, Caporaso N, Weiffenbach B: Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotype. Hum Mol Genet, 1994, 3, 923-926. (Pubitemid 24189960)